Sponsored By

5@5: J&J sells Splenda | Why 'antibiotic-free' chicken isn't enough

Each day at 5 p.m. we collect the five top natural news headlines of the day, making it easy for you to catch up on today's most important natural products industry news.

August 26, 2015

1 Min Read
5@5: J&J sells Splenda | Why 'antibiotic-free' chicken isn't enough

Johnson & Johnson will sell Splenda sweetener to Heartland Food

J&J is abandoning its low-calorie sweetener that's found success over the years—but also controversy. On the other end of the deal, Heartland, which already sells products with sucralose, will gain a brand name. Read more at Bloomberg...


Why we need to get all chickens off drugs

Before giving too much praise to the Big Food companies that are saying they're moving to antibiotic-free meat, let's ask if these measures are really enough to protect public health. Read more at Center for a Livable Future...

Monsanto drops $46 billion bid for Syngenta

After four months of aggressive pursuit, Monsanto is backing of its Swiss competitor. Monsanto says it "will continue to focus on its growth opportunities built on its existing core business to deliver the next wave of transformational solutions for agriculture." Read more at WSJ...


In the search for the perfect sugar substitute, another candidate emerges

Tate & Lyle's new allulose sweetener is profiled by NPR. Read more at NPR...


Omega-3 supplements don't improve memory: study

Mainstream media is reporting on a new study of more than 3,000 elderly people that challenges the link between fish oil supplements and brain health. Read more at Time...

Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like